UK markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.2200+0.2100 (+5.24%)
At close: 04:00PM EDT
4.2000 -0.02 (-0.47%)
After hours: 04:14PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
94,972
86,346
88,638
145,968
77,474
Cost of revenue
49,822
46,021
36,189
61,619
27,512
Gross profit
45,150
40,325
52,449
84,349
49,962
Operating expenses
Research development
128,376
130,821
174,533
167,382
140,032
Selling general and administrative
134,440
127,332
106,079
127,661
93,867
Total operating expenses
262,816
258,153
280,612
295,043
233,899
Operating income or loss
-217,666
-217,828
-228,163
-210,694
-183,937
Interest expense
-
2,410
1,901
1,472
2,672
Total other income/expenses net
-7,658
-878
-847
158
1,804
Income before tax
-227,301
-220,683
-227,278
-204,749
-178,840
Income from continuing operations
-227,301
-220,683
-227,278
-204,749
-178,840
Net income
-227,301
-220,683
-227,278
-204,749
-178,840
Net income available to common shareholders
-227,301
-220,683
-227,278
-204,749
-178,840
Basic EPS
-
-2.24
-2.50
-2.50
-2.44
Diluted EPS
-
-2.24
-2.50
-2.50
-2.44
Basic average shares
-
98,471
90,774
81,779
73,193
Diluted average shares
-
98,471
90,774
81,779
73,193
EBITDA
-
-215,252
-222,530
-201,233
-174,655